Perfil
Chau Cheng worked as Senior Director-Investor Relations at Immunomedics, Inc. from 2004 to 2020.
From 2020 to 2022, served as VP-Investor Relations & Corporate Communications at CytomX Therapeutics, Inc. Also held the position of Vice President-Investor Relations at CG Oncology, Inc. and.
Immunovant, Inc. Education includes an MBA from The Leonard N Stern School of Business, an undergraduate degree from the University of Bradford, and a doctorate from The Open University.
Antiguos cargos conocidos de Chau Cheng.
| Empresas | Cargo | Fin |
|---|---|---|
| IMMUNOVANT, INC. | Contacto de Relaciones con Inversores | 01/08/2024 |
| CYTOMX THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/09/2022 |
| IMMUNOMEDICS, INC. | Contacto de Relaciones con Inversores | 01/12/2020 |
| CG ONCOLOGY, INC. | Contacto de Relaciones con Inversores | - |
Formación de Chau Cheng.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Bradford
University of Bradford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Open University
The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CG Oncology, Inc.
CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
- Bolsa de valores
- Insiders
- Chau Cheng
















